ES8403110A1 - Un procedimiento para la preparacion de pirbuterol. - Google Patents

Un procedimiento para la preparacion de pirbuterol.

Info

Publication number
ES8403110A1
ES8403110A1 ES518971A ES518971A ES8403110A1 ES 8403110 A1 ES8403110 A1 ES 8403110A1 ES 518971 A ES518971 A ES 518971A ES 518971 A ES518971 A ES 518971A ES 8403110 A1 ES8403110 A1 ES 8403110A1
Authority
ES
Spain
Prior art keywords
compound
formula
hydrogen
hydroxymethyl
chem
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES518971A
Other languages
English (en)
Other versions
ES518971A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Publication of ES8403110A1 publication Critical patent/ES8403110A1/es
Publication of ES518971A0 publication Critical patent/ES518971A0/es
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/89Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • C07D213/65One oxygen atom attached in position 3 or 5
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Catalysts (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

PROCEDIMIENTO PARA LA PREPARACION DE PIRBUTEROL, DE FORMULA GENERAL (I) Y COMPUESTOS SIMILARES.CONSISTE EN CALENTAR UN COMPUESTO DE FORMULA (II) EN FORMALDEHIDO ACUOSO Y EN PRESENCIA DE UNA BASE DEBIL. COMO BASE DEBIL SE SUELE UTILIZAR LA TRIETILAMINA.DE APLICACION EN MEDICINA POR SU ACTIVIDAD BRONCODILATADORA, UTILIZANDOSE TAMBIEN EN EL TRATAMIENTO DEL FALLO CARDIACO CONGESTIVO.
ES518971A 1981-02-09 1983-01-13 Un procedimiento para la preparacion de pirbuterol. Granted ES518971A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US23292381A 1981-02-09 1981-02-09

Publications (2)

Publication Number Publication Date
ES8403110A1 true ES8403110A1 (es) 1984-03-01
ES518971A0 ES518971A0 (es) 1984-03-01

Family

ID=22875140

Family Applications (4)

Application Number Title Priority Date Filing Date
ES509430A Granted ES509430A0 (es) 1981-02-09 1982-02-08 Un procedimiento para la preparacion de derivados del pirbuterol.
ES518971A Granted ES518971A0 (es) 1981-02-09 1983-01-13 Un procedimiento para la preparacion de pirbuterol.
ES518973A Granted ES518973A0 (es) 1981-02-09 1983-01-13 Un procedimiento para la preparacion de un derivado del pirbuterol.
ES518972A Expired ES8403111A1 (es) 1981-02-09 1983-01-13 Un procedimiento para la preparacion de pirbuterol.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES509430A Granted ES509430A0 (es) 1981-02-09 1982-02-08 Un procedimiento para la preparacion de derivados del pirbuterol.

Family Applications After (2)

Application Number Title Priority Date Filing Date
ES518973A Granted ES518973A0 (es) 1981-02-09 1983-01-13 Un procedimiento para la preparacion de un derivado del pirbuterol.
ES518972A Expired ES8403111A1 (es) 1981-02-09 1983-01-13 Un procedimiento para la preparacion de pirbuterol.

Country Status (26)

Country Link
EP (4) EP0058072A3 (es)
JP (4) JPS57150665A (es)
KR (1) KR860000623B1 (es)
AR (4) AR231439A1 (es)
AT (2) ATE21691T1 (es)
AU (1) AU530826B2 (es)
CA (1) CA1179677A (es)
CS (1) CS229678B2 (es)
DD (2) DD210034A5 (es)
DE (2) DE3272061D1 (es)
DK (1) DK157541C (es)
EG (1) EG16242A (es)
ES (4) ES509430A0 (es)
FI (1) FI820396L (es)
GR (1) GR75867B (es)
GT (1) GT198273686A (es)
IE (2) IE52326B1 (es)
IL (1) IL64954A (es)
NO (4) NO820371L (es)
NZ (1) NZ199646A (es)
PH (4) PH20622A (es)
PL (4) PL130580B1 (es)
PT (1) PT74397B (es)
SU (4) SU1194273A3 (es)
YU (3) YU42756B (es)
ZA (1) ZA82778B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3615293A1 (de) * 1986-05-06 1987-11-12 Bayer Ag Verwendung von heteroarylethylaminen zur leistungsfoerderung bei tieren, heteroarylethylamine und verfahren zu ihrer herstellung

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3700681A (en) * 1971-02-16 1972-10-24 Pfizer 2-hydroxymethyl-3-hydroxy-6-(1-hydroxy-2-aminoethyl)pyridines
BE795937A (fr) * 1972-03-01 1973-08-27 Pepro Procede d'hydroxymethylation d'une 3-hydroxy-pyridine substituee
AR207639A1 (es) * 1973-12-26 1976-10-22 Pfizer Un procedimiento para preparar pirido (3,2-d)1,3-dioxin-6-epoxietanos y compuestos intermediarios desprovistos de actividad terapeutica
US4031108A (en) * 1974-10-09 1977-06-21 Pfizer Inc. 2-Hydroxymethyl-3-benzyloxypyridine-6-epoxyethane
US3952101A (en) * 1975-04-14 1976-04-20 Smithkline Corporation α-Amino methyl-5-hydroxy-2-pyridinemethanols

Also Published As

Publication number Publication date
DK157541C (da) 1990-06-11
AR229712A1 (es) 1983-10-31
YU201984A (en) 1985-04-30
JPS57150665A (en) 1982-09-17
JPS6059231B2 (ja) 1985-12-24
DD202544A5 (de) 1983-09-21
ES8305721A1 (es) 1983-04-16
ES518972A0 (es) 1984-03-01
YU42908B (en) 1988-12-31
YU43389B (en) 1989-06-30
EP0058071A2 (en) 1982-08-18
IL64954A (en) 1986-03-31
FI820396L (fi) 1982-08-10
IL64954A0 (en) 1982-04-30
EP0058071B1 (en) 1986-07-23
CA1179677A (en) 1984-12-18
ES8403112A1 (es) 1984-03-01
NZ199646A (en) 1985-11-08
JPS6119624B2 (es) 1986-05-17
ES518973A0 (es) 1984-03-01
NO820371L (no) 1982-08-10
IE820275L (en) 1982-08-09
PL130918B1 (en) 1984-09-29
GR75867B (es) 1984-08-02
PL130580B1 (en) 1984-08-31
KR860000623B1 (ko) 1986-05-24
PL239426A1 (en) 1983-04-25
PT74397B (en) 1984-10-09
NO824274L (no) 1982-08-10
EP0058072A3 (en) 1982-08-25
AU8027182A (en) 1982-08-19
AU530826B2 (en) 1983-07-28
PL239428A1 (en) 1983-04-25
DK157541B (da) 1990-01-22
SU1250170A3 (ru) 1986-08-07
AR229373A1 (es) 1983-07-29
PH19167A (en) 1986-01-16
IE52326B1 (en) 1987-09-16
ATE21691T1 (de) 1986-09-15
JPS6059911B2 (ja) 1985-12-27
PL130917B1 (en) 1984-09-29
PH19164A (en) 1986-01-16
PL239427A1 (en) 1983-04-25
ATE20882T1 (de) 1986-08-15
EP0058069A2 (en) 1982-08-18
YU26682A (en) 1985-04-30
EP0058072A2 (en) 1982-08-18
CS229678B2 (en) 1984-06-18
EP0058069B1 (en) 1986-08-27
ZA82778B (en) 1983-01-26
EP0058070A3 (en) 1982-08-25
KR830009028A (ko) 1983-12-17
SU1217253A3 (ru) 1986-03-07
YU201884A (en) 1985-04-30
SU1240354A3 (ru) 1986-06-23
DD210034A5 (de) 1984-05-30
PH20622A (en) 1987-03-06
JPS6135184B2 (es) 1986-08-12
NO824275L (no) 1982-08-10
DE3272793D1 (en) 1986-10-02
YU42756B (en) 1988-12-31
AR231439A1 (es) 1984-11-30
PT74397A (en) 1982-03-01
PL130678B1 (en) 1984-08-31
SU1194273A3 (ru) 1985-11-23
DE3272061D1 (en) 1986-08-28
ES518971A0 (es) 1984-03-01
GT198273686A (es) 1983-07-30
JPS6193164A (ja) 1986-05-12
EP0058070A2 (en) 1982-08-18
PL235000A1 (en) 1983-04-11
IE820273L (en) 1982-08-09
DK52182A (da) 1982-09-17
EG16242A (en) 1989-01-30
ES509430A0 (es) 1983-04-16
AR229374A1 (es) 1983-07-29
ES8403111A1 (es) 1984-03-01
EP0058071A3 (en) 1982-08-25
IE52325B1 (en) 1987-09-16
JPS60208964A (ja) 1985-10-21
NO824273L (no) 1982-08-10
JPS60208962A (ja) 1985-10-21
PH20292A (en) 1986-11-18
EP0058069A3 (en) 1982-09-01

Similar Documents

Publication Publication Date Title
FR2374334A1 (fr) Nouveaux nucleosides utiles comme medicaments et procede pour leur preparation
ES8703460A1 (es) Un procedimiento para preparar aminoacil-ladanos
MY101618A (en) Intermediates for the production of epipodophyloxin and related compounds and processes for the preparation and use thereof
CS909186A2 (en) Zpusob vyroby chinolinkarboxylovych kyselin
ES8403112A1 (es) Un procedimiento para la preparacion de un derivado del pirbuterol.
ES8307249A1 (es) Procedimiento de preparacion de nuevos derivados del adamantano.
ES8101592A1 (es) Un procedimiento para la preparacion del acido 7-oxo-1-aza- biciclo (3.2.0)hept-2-en-2-carboxilico
JPS57192392A (en) Production of 3-alkoxymethylcephalosporin
ES8503029A1 (es) Un procedimiento para preparar acido 3-arginil-2-bencil(op-hidroxibencil)-propionico.
GB1490289A (en) Intermediates and production thereof for use in the preparation of 6-(2-phenyl-2-(guanylureidoacetamido)acetamido)penicillanic acid
TNSN88070A1 (fr) Procede de preparation de l'acide (pyridyl-3)-3-1h, 3h-pyrrolo (1,2-c) thiazolecarboxylique-7dextrogyre
FR2359133A1 (fr) Procede de preparation de (vinyl 2,2-disubstitue)-g-butyrolactones
JPS51149287A (en) Process for preparing 5-fluorouracil
JPS5432480A (en) Novel preparation of piperidine derivatives
JPS51115402A (en) Process for preparation of alpha-amino acid
SU1089087A1 (ru) Способ получени 2,4-диаминобензонитрила
JPS55133357A (en) Preparation of 1-cyano-2-hydroxy-3-phthalimidopropane
MX9700331A (es) Proceso mejorado para r(+)1,2,3,6-tetrahidro-4-fenil-1-[(3-fenil-3-ciclohexen-1-il)metil]pirid ina, un agente del sistema nervioso central.
EP0280868A3 (en) Imidazo- and triazolothiadiazines, process for their preparation, medicaments containing them and their use as well as some of the intermediates obtained during the preparation of said compounds
DE3665590D1 (en) Method for the preparation of 4'-0-tetrahydropyranyladriamycin b
ES479628A1 (es) Un procedimiento para preparar clorhidrato de p-clorofenoxia-acetil-piperonilpiperacina.
JPS53149975A (en) Preparation of imidazolylbenzophenones
JPS53119822A (en) Preparation of 2-dimethylaminoethylisothiocyanate
JPS5490184A (en) Preparation of 5-fluoro-orotic acid
JPS53137913A (en) Preparation of cis-epoxysuccinic acid or cis-epoxysuccinate salt

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20031129